FDA Inspection 1018713 — NewMarket Health, LLC
The FDA completed an inspection of NewMarket Health, LLC on Jul 13, 2017 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 13, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baltimore, MD (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)